Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Woollard, Kevin J ^a,b   Lumsden, Natalie G ^a   Andrews, Karen L ^a   Aprico, Andrea ^a   Harris, Emma ^a   Irvine, Jennifer C ^a   Jefferis, Ann Maree ^a   Fang, Lu ^a   Kanellakis, Peter ^a   Bobik, Alex ^a   Chin Dusting, Jaye P F ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD68 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; RANTES; TRANSGELIN; APOLIPOPROTEIN E; CCL2 PROTEIN, MOUSE; FAT INTAKE; PTPRC PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; LIPID COMPOSITION; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOSIS; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; FAT INTAKE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD45; APOLIPOPROTEINS E; CHEMOKINE CCL2; DIETARY FATS; DISEASE MODELS, ANIMAL; MACROPHAGES; MICE; MICE, KNOCKOUT; P-SELECTIN; PLAQUE, ATHEROSCLEROTIC;

EID: 84901357995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097422     Document Type: Article

References (48)

1. Gersh BJ, Sliwa K, Mayosi BM, Yusuf S (2010) Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 31: 642-648.
2. Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17: 1410-1422.
3. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, et al. (2006) Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12: 1075-1080. (Pubitemid 44353389)
4. Woollard KJ, Chin-Dusting J (2010) P-selectin antagonism in inflammatory disease. Curr Pharm Des 16: 4113-4118.
5. Epperson TK, Patel KD, McEver RP, Cummings RD (2000) Noncovalent association of P-selectin glycoprotein ligand-1 and minimal determinants for binding to P-selectin. J Biol Chem 275: 7839-7853. (Pubitemid 30159691)
6. Johnston GI, Cook RG, McEver RP (1989) Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 56: 1033-1044. (Pubitemid 19091015)
7. Norman KE, Katopodis AG, Thoma G, Kolbinger F, Hicks AE, et al. (2000) P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo. Blood 96: 3585-3591.
8. Urzainqui A, Serrador JM, Viedma F, Yanez-Mo M, Rodriguez A, et al. (2002) ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. Immunity 17: 401-412. (Pubitemid 35223530)
9. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689. (Pubitemid 47327397)
10. Manka D, Collins RG, Ley K, Beaudet AL, Sarembock IJ (2001) Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein e-deficient mice. Circulation 103: 1000-1005. (Pubitemid 32183807)
11. Phillips JW, Barringhaus KG, Sanders JM, Hesselbacher SE, Czarnik AC, et al. (2003) Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation 107: 2244-2249. (Pubitemid 36547220)
12. Woollard KJ (2005) Soluble bio-markers in vascular disease: much more than gauges of disease? Clin Exp Pharmacol Physiol 32: 233-240.
13. Ridker PM, Buring JE, Rifai N (2001) Soluble P-selectin and the risk of future cardiovascular events. Circulation 103: 491-495. (Pubitemid 32116231)
14. Woollard KJ, Kling D, Kulkarni S, Dart AM, Jackson S, et al. (2006) Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ Res 98: 149-156. (Pubitemid 43970215)
15. Woollard KJ, Suhartoyo A, Harris EE, Eisenhardt SU, Jackson SP, et al. (2008) Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res 103: 1128-1138.
16. Wang HB, Wang JT, Zhang L, Geng ZH, Xu WL, et al. (2007) P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol 8: 882-892. (Pubitemid 47099040)
17. Kisucka J, Chauhan AK, Zhao BQ, Patten IS, Yesilaltay A, et al. (2009) Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 113: 6015-6022.
18. Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, et al. (2013) A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ Res 113: 252-265.
19. Gaspari T, Welungoda I, Widdop RE, Simpson RW, Dear AE (2013) The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-/-) mouse model. Diab Vasc Dis Res 10: 353-360.
20. Tan KT, Tayebjee MH, Lynd C, Blann AD, Lip GY (2005) Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann Med 37: 61-66. (Pubitemid 40342426)
21. Khew-Goodall Y, Butcher CM, Litwin MS, Newlands S, Korpelainen EI, et al. (1996) Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood 87: 1432-1438.
22. Storey RF, Sanderson HM, White AE, May JA, Cameron KE, et al. (2000) The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 110: 925-934.
23. Matzdorff AC, Kemkes-Matthes B, Voss R, Pralle H (1996) Comparison of beta-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation. Haemostasis 26: 98-106.
24. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, et al. (1994) P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 91: 8767-8771.
25. Elstad MR, La Pine TR, Cowley FS, McEver RP, McIntyre TM, et al. (1995) P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes. J Immunol 155: 2109-2122.
26. Polgar J, Matuskova J, Wagner DD (2005) The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 3: 1590-1596. (Pubitemid 41716543)
27. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD (2000) Procoagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 97: 13835-13840.
28. Geng YJ, Libby P (1995) Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 147: 251-266.
29. Lutgens E, de Muinck ED, Kitslaar PJ, Tordoir JH, Wellens HJ, et al. (1999) Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res 41: 473-479. (Pubitemid 29087344)
30. Clowes AW, Reidy MA, Clowes MM (1983) Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49: 327-333. (Pubitemid 13012062)
31. Littlewood TD, Bennett MR (2003) Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 14: 469-475. (Pubitemid 37297301)
32. Schaub FJ, Liles WC, Ferri N, Sayson K, Seifert RA, et al. (2003) Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha. Circ Res 93: 515-522. (Pubitemid 37163231)
33. Schaub FJ, Han DK, Liles WC, Adams LD, Coats SA, et al. (2000) Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med 6: 790-796. (Pubitemid 30469428)
34. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20: 1262-1275. (Pubitemid 30262927)
35. Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7: 77-86.
36. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117: 185-194. (Pubitemid 46048465)
37. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, et al. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117: 195-205. (Pubitemid 46048466)
38. Woollard KJ (2013) Immunological aspects of atherosclerosis. Clin Sci (Lond) 125: 221-235.
39. Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, et al. (2013) Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19: 1166-1172.
40. Jaipersad AS, Lip GY, Silverman S, Shantsila E (2014) The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol 63: 1-11.
41. von Hundelshausen P, Petersen F, Brandt E (2007) Platelet-derived chemokines in vascular biology. Thromb Haemost 97: 704-713. (Pubitemid 46804313)
42. Gear AR, Camerini D (2003) Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10: 335-350. (Pubitemid 39004260)
43. Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95: 858-866. (Pubitemid 39435000)
44. Baltus T, Weber KS, Johnson Z, Proudfoot AE, Weber C (2003) Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 102: 1985-1988. (Pubitemid 37122370)
45. Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, et al. (2003) Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 89: 506-512. (Pubitemid 36329242)
46. Virani SS, Nambi V, Hoogeveen R, Wasserman BA, Coresh J, et al. (2011) Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J 32: 459-468.
47. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69: 377-381. (Pubitemid 23171108)
48. Waxman S, Ishibashi F, Muller JE (2006) Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation 114: 2390-2411. (Pubitemid 44848285)